To detail and provide novel in-vitro and in-vivo information on the contribution of collagen IV binding on pharmacokinetics, haemostatic potential and tissue distribution of engineered recombinant factor IX,
Insights into the contribution of tailored collagen binding to half-life of designed factor IX fusion proteins
Alessio Branchini
2021
Abstract
To detail and provide novel in-vitro and in-vivo information on the contribution of collagen IV binding on pharmacokinetics, haemostatic potential and tissue distribution of engineered recombinant factor IX,File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
